RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure–response relationship
Titel:
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure–response relationship
Auteur:
Nakagawa, Kazuhiko Garon, Edward B. Gao, Ling Callies, Sophie Zimmermann, Annamaria Walgren, Richard Visseren-Grul, Carla Reck, Martin